Sa1526 CATENIBACTERIUM MITSUOKAI PROMOTES TUMOR IMMUNOSUPPRESSION THROUGH METABOLIC REPROGRAMMING OF PMN-MDSC IN HEPATOCELLULAR CARCINOMA

Tu1545 CLINICAL SIGNIFICANCE OF SERUM C-REACTIVE PROTEIN LEVELS FOR PREDICTING LENVATINIB-TREATED UNRESECTABLE HEPATOCELLULAR CARCINOMA: A ...

Mo1503 GLOBAL PREVALENCE, CLINICAL CHARACTERISTICS, SURVEILLANCE, TREATMENT ALLOCATION, AND OUTCOMES OF ALCOHOL-ASSOCIATED HEPATOCELLULAR CARCINOMA: ...

Tu1543 RURALITY OF RESIDENCE AND DISPARITY IN INCIDENT HEPATOCELLULAR CARCINOMA AMONG VIETNAM WAR VETERANS

Tu1586 SIMULTANEOUS ULTRAOUND AND CLINIC VISIT FOR HEPATOCELLULAR CARCINOMA SCREENING

91 A CIRCRNA BASED-LIQUID BIOPSY FOR NONINVASIVE AND EARLY DETECTION OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Sa1530 PERCENTAGE OF BACTEROIDES SPEICIES IN MICROBIOME AFFECT THERAPEUTIC EFFICACY OF IMMUNE CHECKPOINT INHIBITORS FOR HEPATOCELLULAR CARCINOMA.

Su1527 HIGHER INCIDENCE OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN LEAN VS. OVERWEIGHT/OBESE VETERANS WITH MASLD

Sa1648 CHECKING IS LACKING: SUBOPTIMAL SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH SUSTAINED VIROLOGIC RESPONSE AFTER DIRECT-ACTING ANTIVIRAL ...

Tu1538 RISK OF BILIARY STRICTURES AFTER RADIATION THERAPY FOR HEPATOCELLULAR CARCINOMA (HCC)